Arcosa, Inc. (ACA) — Fair Value Analysis

Base-case fair value (P50): $127.17 · Current price: $145.40 · Verdict: Fairly Valued

The Verdict on ACA

ARCOSA INC (ACA) is currently assessed as Fairly Valued by our Monte Carlo simulations. At a $145.40 market price, ACA trades above our median fair value (P50) of $127.17. This indicates an -12.5% difference between the current market valuation and the P50 fair value, positioning ACA slightly above its calculated intrinsic value. While the simulations point to $127.17 as a robust median target, the difference from $145.40 places the company squarely in the fairly valued category, rather than significantly overvalued or undervalued, based on our comprehensive model.

How ACA stacks up against Industrials

Despite being deemed Fairly Valued, ACA’s operational and financial health is categorized as weak relative to the broader Industrials sector. This quality tier suggests that while its current price of $145.40 is close to our median fair value of $127.17, the company may face more significant headwinds or possess fewer competitive advantages compared to sector peers. The weak quality rating, combined with the -12.5% difference, implies that even a minor market correction or operational slip could see the stock deviate further from its $127.17 median fair value in various downside scenarios generated by the Monte Carlo model.

What this means for investors

For investors considering ARCOSA INC (ACA), the Fairly Valued verdict, despite the stock trading at $145.40 against a median fair value of $127.17, warrants attention. The -12.5% difference is modest, confirming the "fairly valued" assessment. However, the company's weak quality tier within the Industrials sector adds a layer of caution. This quality tier suggests that while the P50 provides a central estimate, ACA might have a wider range of potential outcomes, particularly in adverse conditions. To fully understand the risk-reward profile, including detailed bear-case and bull-case scenarios and the full Monte Carlo distribution, sign up for a free FairCurve account and track ACA’s fair value as new fundamentals are released.